ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,615.35
0.55%
US Tech 100
19,804.00
0.64%
Dow Jones
40,000.90
0.62%
Brent Oil
84.57
0.00%
Bitcoin
59,440.26
0.35%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aevi Genomic Medicine Inc (GNMX)

  7. Aevi Genomic Medicine Inc (GNMX) News

GNMX

Aevi Genomic Medicine (GNMX)

Aevi Genomic Medicine Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GNMX
DateTimeSourceHeadlineSymbolCompany
05/25/20186:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GNMXAevi Genomic Medicine Inc
05/16/20184:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
05/16/20184:38PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:GNMXAevi Genomic Medicine Inc
05/16/20184:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
05/16/20184:28PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:GNMXAevi Genomic Medicine Inc
05/16/20184:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
05/16/20184:23PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:GNMXAevi Genomic Medicine Inc
05/15/20188:32AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GNMXAevi Genomic Medicine Inc
05/15/20188:30AMPR Newswire (US)Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business UpdateNASDAQ:GNMXAevi Genomic Medicine Inc
05/15/20188:25AMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:GNMXAevi Genomic Medicine Inc
05/15/20188:15AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:GNMXAevi Genomic Medicine Inc
05/15/20188:15AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:GNMXAevi Genomic Medicine Inc
05/15/20188:04AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GNMXAevi Genomic Medicine Inc
05/01/20186:21AMEdgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:GNMXAevi Genomic Medicine Inc
04/27/20184:08PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:GNMXAevi Genomic Medicine Inc
04/27/20184:05PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:GNMXAevi Genomic Medicine Inc
03/21/20184:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GNMXAevi Genomic Medicine Inc
03/20/20188:00AMPR Newswire (US)Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare ConferenceNASDAQ:GNMXAevi Genomic Medicine Inc
03/13/20187:34AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:GNMXAevi Genomic Medicine Inc
03/13/20187:30AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GNMXAevi Genomic Medicine Inc
03/13/20187:30AMPR Newswire (US)Aevi Genomic Medicine Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business UpdateNASDAQ:GNMXAevi Genomic Medicine Inc
03/07/20188:00AMPR Newswire (US)Aevi Genomic Medicine Expands Collaboration with Kyowa Hakko KirinNASDAQ:GNMXAevi Genomic Medicine Inc
03/06/20184:13PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GNMXAevi Genomic Medicine Inc
03/06/20188:00AMPR Newswire (US)Aevi Genomic Medicine to Host Conference Call to Announce Fourth Quarter and Year End 2017 Financial ResultsNASDAQ:GNMXAevi Genomic Medicine Inc
02/13/20184:47PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GNMXAevi Genomic Medicine Inc
02/13/20184:31PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:GNMXAevi Genomic Medicine Inc
02/13/20184:29PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GNMXAevi Genomic Medicine Inc
02/06/201812:10PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GNMXAevi Genomic Medicine Inc
01/05/20188:02AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:GNMXAevi Genomic Medicine Inc
01/05/20186:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GNMXAevi Genomic Medicine Inc
 Showing the most relevant articles for your search:NASDAQ:GNMX

Your Recent History

COIN
XRPUSD
Ripple
USOTC
GRST
Ethema Health (PK)
USOTC
ERHE
ERHC Energy (CE)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
IQST
iQSTEL (QX)
USOTC
VPLM
Voip Pal Com (QB)
COIN
BTCUSD
Bitcoin
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
FNMA
Fannie Mae (QB)
USOTC
RDGL
Vivos (QB)
USOTC
BIEL
Bioelectronics (PK)
NASDAQ
AVXL
Anavex Life Sciences
NASDAQ
COOP
Mr Cooper
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
RNVA
Rennova Health (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved